Investigating how aging affects mutations in brain cells related to Alzheimer's disease

Spatial single-cell analysis of somatic mutation in human brain during aging and neurodegeneration

['FUNDING_OTHER'] · UNIV OF MASSACHUSETTS MED SCH WORCESTER · NIH-10687449

This study is looking at how changes in brain cells might play a role in aging and diseases like Alzheimer's, with the hope of finding new ways to help people affected by these conditions.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorUNIV OF MASSACHUSETTS MED SCH WORCESTER (nih funded)
Locations1 site (WORCESTER, UNITED STATES)
Trial IDNIH-10687449 on ClinicalTrials.gov

What this research studies

This research focuses on understanding how somatic mutations in brain cells contribute to aging and neurodegeneration, particularly in Alzheimer's disease. By utilizing advanced single-cell sequencing techniques, the study aims to identify and characterize these mutations at a cellular level, which could reveal important insights into the mechanisms of neuron loss. Patients may benefit from this research as it seeks to uncover the genetic factors that accelerate neurodegeneration, potentially leading to new therapeutic strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research include older adults experiencing cognitive decline or those diagnosed with Alzheimer's disease.

Not a fit: Patients with early-onset dementia not related to Alzheimer's or those with other unrelated neurological conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in understanding and treating Alzheimer's disease and related dementias.

How similar studies have performed: Previous research has shown promising results in understanding genetic mutations in neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

WORCESTER, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.